Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06525974
EARLY_PHASE1
Clinical Study to Evaluate the Possible Efficacy and Safety of Febuxostat in Patients With Ulcerative Colitis Treated With Mesalamine
Sponsor: Tanta University
View on ClinicalTrials.gov
Summary
Evaluation the possible efficacy and safety of febuxostat in patients with ulcerative colitis treated with mesalamine.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
46
Start Date
2024-09-01
Completion Date
2026-12-30
Last Updated
2024-07-29
Healthy Volunteers
No
Conditions
Interventions
DRUG
Febuxostat
40mg of Febuxostat once daily
DRUG
Mesalamine
1 g mesalamine three times daily for 3 months.